These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23563893)

  • 1. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
    Seillier A; Martinez AA; Giuffrida A
    Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A; Giuffrida A
    Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia.
    Seillier A
    Exp Brain Res; 2024 May; 242(5):1149-1160. PubMed ID: 38489023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
    J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
    Seillier A; Giuffrida A
    Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.
    Trezza V; Damsteegt R; Manduca A; Petrosino S; Van Kerkhof LW; Pasterkamp RJ; Zhou Y; Campolongo P; Cuomo V; Di Marzo V; Vanderschuren LJ
    J Neurosci; 2012 Oct; 32(43):14899-908. PubMed ID: 23100412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.
    Seillier A; Giuffrida A
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):298-309. PubMed ID: 26706691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
    Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB
    Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
    Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597.
    Matricon J; Seillier A; Giuffrida A
    Neurosci Res; 2016 Sep; 110():49-58. PubMed ID: 27091613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
    Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
    Aguilar DD; Giuffrida A; Lodge DJ
    J Psychopharmacol; 2016 Feb; 30(2):169-81. PubMed ID: 26510449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates.
    Butler RK; Rea K; Lang Y; Gavin AM; Finn DP
    Pain; 2008 Dec; 140(3):491-500. PubMed ID: 19004548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway.
    McLaughlin RJ; Hill MN; Bambico FR; Stuhr KL; Gobbi G; Hillard CJ; Gorzalka BB
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):664-71. PubMed ID: 22325231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
    Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
    Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
    Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
    Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.